BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 867315)

  • 1. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M; Watanabe T; Koike K; Sakuragawa N
    Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platelet research method and its application in the study of "huo xuo hua yu"].
    Wang Z
    Zhong Xi Yi Jie He Za Zhi; 1984 Aug; 4(8):501-4. PubMed ID: 6238720
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic agents, pharmacologic principles].
    Markwardt F
    Z Arztl Fortbild (Jena); 1986; 80(14):565-70. PubMed ID: 3765695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet aggregation increase. An unexpected result in fibrinolytic therapy].
    Griguer P
    Ann Cardiol Angeiol (Paris); 1973; 22(3):223-30. PubMed ID: 4731540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibition of platelet aggregation and its clinical use (author's transl)].
    Cepelák V
    Cas Lek Cesk; 1974 Jan; 113(2):51-5. PubMed ID: 4154807
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
    Eisen M; Napp HE; Vock R
    Urologe A; 1975 May; 14(3):132-6. PubMed ID: 1154559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet function with bencyclane.
    Bédi J; Pálos AL
    Ther Hung; 1976; 24(2):50-5. PubMed ID: 982339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of elastase on platelet adhesiveness and platelet aggregation (author's transl)].
    Kobayashi T; Sakaki H; Toyoshima H; Fujita S; Uesugi S; Endo Y; Satoh M
    Rinsho Byori; 1981 Mar; 29(3):295-8. PubMed ID: 6911161
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3',5'-adenosine monophosphate phosphodiesterase.
    Tang SS; Frojmovic MM
    J Lab Clin Med; 1980 Feb; 95(2):241-57. PubMed ID: 6243686
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cyclonamine on blood platelets. II. Changes in the surface charge and inhibition of the release reaction.
    Sack ES; Cerutti N
    Medicina (B Aires); 1973; 3(6):685-94. PubMed ID: 4805048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substances decreasing the aggregation and adhesiveness of thrombocytes (review of the literature)].
    Lakin KM; Fel'dbaum VA; Lebedeva AA
    Farmakol Toksikol; 1971; 34(1):104-13. PubMed ID: 4397898
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of salicylic acid and pyridinolcarbamate on the platelet aggregation (author's transl)].
    Altman R; Rouvier J; Taboada S; Mosquera G
    Sangre (Barc); 1974; 19(4):385-98. PubMed ID: 4445961
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-acting fibrinolytic drugs. Drugs acting on platelet aggregation].
    de Nicola P
    Angeiologie; 1967; 20():Suppl:45-53. PubMed ID: 5621507
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.